Navigation Links
Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones

GLADSTONE, N.J., May 6, 2013 /PRNewswire/ -- In 2003, Lisa B. Bair opened The Hobart Group in her home with one client and $200,000 in revenue. Over 10 years, Hobart Group Holdings has grown into a $30+ million company with 115 employees and 3 offices and manages business for 12 of the top 20 global pharmaceutical companies. The icing on the anniversary cake was securing the Agency of the Year nomination by industry experts.

"Our unbelievable growth over the past 10 years stems from a culture that thrives on the passion to discover new approaches that improve patient care through innovative customer initiatives," says Bair. "Hobart has always been the agency to raise the bar, set the trends, and create new tools in the managed markets space. 2013 will be no different—we are committed to further elevating the space with new product initiatives and distinctive, game-changing alliances," says the Founder and CEO of Hobart Group Holdings.

Hobart Group Holdings provides comprehensive access and reimbursement support to an impressive client base that includes many of the largest global pharmaceutical companies—Lilly, Sanofi, Pfizer, GlaxoSmithKline, Merck, Bayer HealthCare, and Astellas, to name a few.

The company's growth has not gone unrecognized. Over the past few years, Hobart has received many accolades, including

  • 2010: Ernst & Young named Bair one of the top 10 women entrepreneurs in the United States
  • 2011: Hobart was recognized as one of the 50 Fastest Growing Women-Owned/Led Companies™ in North America awarded by the Women Presidents' Organization and American Express
  • 2011 and 2012: Hobart was listed in Inc. magazine's top 500/5000 Fastest Growing Companies 
  • 2012 and 2013: Hobart was honored as one of the Best Places to Work in New Jersey
  • 2013: Hobart was nominated for Agency of the Year by Med Ad News

"Our exceptional growth and success is attributed to the fact that Hobart Group Holdings is the largest dedicated payer agency in the United States. The pharmaceutical industry has recognized the advantage Hobart offers as a payer-focused agency and continually seeks out Hobart to assist in developing customized access and reimbursement approaches," says Dan Renick , RPh, President of Hobart Group Holdings.

Future Plans

Hobart Innovations, a division of Hobart Group Holdings under the leadership of Larry Blandford , is developing digital enterprise capabilities designed to improve the dialogue and align objectives between payers and pharmaceutical companies. The new products will provide tremendous opportunities for pharma clients to elevate the dialogue with payer customers. 

About Hobart Group Holdings

Hobart Group Holdings is a consortium of 3 full-service, thought-leader agencies, including The Hobart Group in New Jersey, Hobart Forte in New York City, and Hobart Core in Chicago.

Hobart's core competencies include payer value proposition development, launch planning, payer market research, quality initiatives, HEOR, sales training, and contracting and pricing expertise.

What sets Hobart apart is the strategic services department, which is composed of former payer decision makers with extensive knowledge across the spectrum of organized customer channels. The strategic team has more than 100 years of experience working with, and working as, pharmacy directors, medical directors, contracting managers, case managers, and quality directors for MCOs, PBMs, government, payers, IDNs, hospitals, and LTC facilities. This experience allows Hobart to consistently deliver impactful solutions that directly align with clients' marketing objectives.

For more information contact:

Sue Patton


SOURCE Hobart Group Holdings
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. William McGuire, Former UnitedHealth Group CEO, Joins Rebiotix Inc. Board of Directors
2. Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in China
3. Industry Group To Vow That Boston Terror Attack Victims "Will Walk And Run Again"
4. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
5. Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
6. featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
7. Bipartisan Group of 124 Lawmakers Express Concern That Medicare Cuts to Life-Sustaining Cancer Drugs Threatening Patient Care
8. BioRestorative Therapies Appoints ProActive Capital Group as Capital Markets & Digital Media Advisor
9. Foundation Venture Capital Group Invests In Company Developing Implantable Meniscus for Knee Repair
10. Panelists Announced for Decision Resources Group One-day Biologics and Biosimilars Seminar in San Diego
11. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
Post Your Comments:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):